CEACAM5 and colorectal cancer: We tested the in vitro binding efficacy of engineered E. coli to two colorectal cancer cell lines withdifferent CEA-expression strengths: (i) Caco2 with high CEA expressionlevel and (ii) SW480 with low CEA expression level.28